Drug Profile
Conjugated estrogens oral - Teva Pharmaceutical Industries
Alternative Names: Cenestin; Synthetic conjugated estrogens, ALatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Duramed Pharmaceuticals Inc
- Class Estradiol congeners; Hormonal replacements; Osteoporosis therapies
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Atrophic vaginitis; Vasomotor symptoms
Most Recent Events
- 12 Nov 2020 Avion Pharmaceuticals acquires the rights to relaunch conjugated estrogen oral tablets in USA
- 12 Nov 2020 Avion Pharmaceuticals plans to relaunch conjugated estrogen oral tablets in USA
- 12 Nov 2020 Efficacy and adverse events data from a clinical trial in Vasomotor symptoms released by Avion Pharmaceuticals